热门话题-Tango Therapeutics在启动5亿美元股票发行后股价回落

路透中文
Jun 09
热门话题-Tango <a href="https://laohu8.com/S/LENZ">Therapeutics</a>在启动5亿美元股票发行后股价回落

6月8日 - ** Tango Therapeutics TNGX.O 股价在盘后交易中下跌3.2%,至29.95美元,该公司正计划进行股权融资

** TNGX 启动 (link) 5亿美元股票发行

** 摩根大通、Leerink、Cantor Fitzgerald和Stifel担任联合簿记管理人

** 周一,TNGX股价飙升53%,收于创纪录高点30.93美元,此前该公司实验性胰腺癌药物vopimetostat与Revolution Medicines RVMD.O 的daraxonrasib联合使用,在一项小型研究中显示出强劲的早期结果 (link)

** 根据招股说明书,TNGX计划将本次发行所得净额用于一般用途,包括研发、关键性试验费用以及为其一项或多项候选产品的潜在商业化做准备等 (link)

** 总部位于马萨诸塞州波士顿的TNGX目前流通股约为1.446亿股,当前市值约为45亿美元

** 收盘时,该股年内累计涨幅达249%

** 据伦敦证券交易所集团(LSEG)数据显示,12位分析师中有10位给予该股“强烈买入”或“买入”评级,2位建议“持有”;目标价中位数为35美元

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10